UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial

Molecular therapy, 2019-11, Vol.27 (11), p.1930-1938

2019

Volltextzugriff (PDF)

Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility

Gene therapy, 2016-02, Vol.23 (2), p.135-143

2016

Volltextzugriff (PDF)

Caregiver Perspectives on Patient Participation in Biological Pediatric Cancer Research

Children (Basel), 2022-06, Vol.9 (6), p.901

2022

Volltextzugriff (PDF)

A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors

Frontiers in pediatrics, 2023-05, Vol.11, p.1183295-1183295

2023

Volltextzugriff (PDF)

Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients

Clinical cancer research, 2017-07, Vol.23 (14), p.3566-3574

2017

Volltextzugriff (PDF)

Nothing but NET: A review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy

Pediatric blood & cancer, 2015-01, Vol.62 (1), p.5-11

2015

Volltextzugriff (PDF)

Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor

Journal of clinical oncology, 2023-01, Vol.41 (3), p.508-516

2023

Volltextzugriff (PDF)

Cabozantinib for relapsed neuroblastoma: Single institution case series

Pediatric blood & cancer, 2020-07, Vol.67 (7), p.e28317-n/a

2020

Volltextzugriff (PDF)

Multimodality treatment for recurrent neuroblastoma in the central nervous system

Pediatric blood & cancer, 2023-04, Vol.70 (4), p.e30227-n/a

2023

Volltextzugriff (PDF)

Point light detection with UO2

Journal of applied physics, 2021-08, Vol.130 (7)

2021

Volltextzugriff (PDF)

Impact of diagnostic and end‐of‐induction Curie scores with tandem high‐dose chemotherapy and autologous transplants for metastatic high‐risk neuroblastoma: A report from the Children's Oncology Group

Pediatric blood & cancer, 2023-08, Vol.70 (8), p.e30418-n/a

2023

Volltextzugriff (PDF)

Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children

Molecular therapy. Oncolytics, 2015, Vol.2, p.15015-15015, Article 15015

2015

Volltextzugriff (PDF)

Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children

Molecular therapy. Oncolytics, 2015, Vol.2, p.15016-15016, Article 15016

2015

Volltextzugriff (PDF)

Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation

Oncotarget, 2017-03, Vol.8 (11), p.17412-17427

2017

Volltextzugriff (PDF)

Golden-winged Warbler Ecology, Conservation, and Habitat Management

1, 2017

Volltextzugriff (PDF)

VEGF Blockade Enables Oncolytic Cancer Virotherapy in Part by Modulating Intratumoral Myeloid Cells

Molecular therapy, 2013-05, Vol.21 (5), p.1014-1023

2013

Volltextzugriff (PDF)

252 Interim results of an open-label trial to evaluate elexacaftor-tezacaftorivacaftor in individuals with cystic fibrosis and an N1303K mutation who are not eligible for modulator treatment

Journal of cystic fibrosis, 2023-10, Vol.22, p.S128-S128

2023

Volltextzugriff (PDF)

280 Induced pluripotent stem cell–based airway epithelial platform for investigating personalized responses to CFTR modulators

Journal of cystic fibrosis, 2023-10, Vol.22, p.S141-S142

2023

Volltextzugriff (PDF)

242 An open-label trial to evaluate elexacaftor-tezacaftor-ivacaftor and induced pluripotent stem cell–derived model systems in individuals with residual CFTR activity

Journal of cystic fibrosis, 2023-10, Vol.22, p.S123-S124

2023

Volltextzugriff (PDF)

667: Development of an iPSC-based airway epithelial platform for evaluating patient-specific responses to modulators

Journal of cystic fibrosis, 2021-11, Vol.20, p.S316

2021

Volltextzugriff (PDF)

572: Clinical and iPSC-derived airway epithelial responses to elexacaftor/tezacaftor/ivacaftor in CF patients without an approved modulator

Journal of cystic fibrosis, 2021-11, Vol.20, p.S271

2021

Volltextzugriff (PDF)

606 Focused clinical trials of modulator response for rare cystic fibrosis genotypes

Journal of cystic fibrosis, 2022-10, Vol.21, p.S336-S336

2022

Volltextzugriff (PDF)

638: Demonstration of pharmacologic N1303 K CFTR rescue in heterologous and human tissue-based model systems

Journal of cystic fibrosis, 2021-11, Vol.20, p.S303

2021

Volltextzugriff (PDF)

Impact of diagnostic and end-of-induction Curie scores in tandem autologous hematopoietic cell transplant for patients with high-risk neuroblastoma: A report from the Children’s Oncology Group

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10027-10027

2022

Volltextzugriff (PDF)

Rhabdomyosarcoma in Adolescents and Young Adults: A 25-Year Review at Nationwide Children's Hospital

Journal of adolescent and young adult oncology, 2011-12, Vol.1 (4), p.164-167

2011

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial

Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility

Caregiver Perspectives on Patient Participation in Biological Pediatric Cancer Research

A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors

Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients

Nothing but NET: A review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy

Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor

Cabozantinib for relapsed neuroblastoma: Single institution case series

Multimodality treatment for recurrent neuroblastoma in the central nervous system

Point light detection with UO2

Impact of diagnostic and end‐of‐induction Curie scores with tandem high‐dose chemotherapy and autologous transplants for metastatic high‐risk neuroblastoma: A report from the Children's Oncology Group

Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children

Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children

Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation

Golden-winged Warbler Ecology, Conservation, and Habitat Management

VEGF Blockade Enables Oncolytic Cancer Virotherapy in Part by Modulating Intratumoral Myeloid Cells

252 Interim results of an open-label trial to evaluate elexacaftor-tezacaftorivacaftor in individuals with cystic fibrosis and an N1303K mutation who are not eligible for modulator treatment

280 Induced pluripotent stem cell–based airway epithelial platform for investigating personalized responses to CFTR modulators

242 An open-label trial to evaluate elexacaftor-tezacaftor-ivacaftor and induced pluripotent stem cell–derived model systems in individuals with residual CFTR activity

667: Development of an iPSC-based airway epithelial platform for evaluating patient-specific responses to modulators

572: Clinical and iPSC-derived airway epithelial responses to elexacaftor/tezacaftor/ivacaftor in CF patients without an approved modulator

606 Focused clinical trials of modulator response for rare cystic fibrosis genotypes

638: Demonstration of pharmacologic N1303 K CFTR rescue in heterologous and human tissue-based model systems

Impact of diagnostic and end-of-induction Curie scores in tandem autologous hematopoietic cell transplant for patients with high-risk neuroblastoma: A report from the Children’s Oncology Group

Rhabdomyosarcoma in Adolescents and Young Adults: A 25-Year Review at Nationwide Children's Hospital

Suchergebnisse filtern